DavidPatrickSparlingMDPhD
Pediatric Endocrinology • Oklahoma City, OKPediatric Diabetes Endocrinology
Section Chief
Dr. Sparling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 Children's Avenue, Ste 4D
Suite 4D
Oklahoma City, OK 73104Phone+1 405-271-3303
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Endocrinology, 2011 - 2015- New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2009 - 2011
University of Oklahoma College of MedicineClass of 2009
Certifications & Licensure
OK State Medical License 2015 - 2025
NY State Medical License 2011 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- 16 citationsDiabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Regi...Nudrat Noor, Osagie Ebekozien, Laura Levin, Sheri L. Stone, David P. Sparling
Diabetes Care. 2021-06-18 - 1 citationsInhibition of γ-secretase in adipocytes leads to altered IL-6 secretion and adipose inflammationDavid P. Sparling, Nile Mccullough, Utpal B. Pajvani, Mary Beth Humphrey
Adipocyte. 2020-06-30 - 10 citationsWeight Loss Results in Increased Expression of Anti-Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue.Robert M. Jackson, Beth A. Griesel, Kevin R. Short, David P. Sparling, Willard M. Freeman
Obesity. 2019-12-01
Authored Content
- Real-time continuous glucose monitoring reduced costly diabetes-related events in adolescents and young adults despite lack of short-term reduction in hemoglobin A1cApril 2023
Press Mentions
- New Diabetes Treatment Could Change the Future of the DiseaseMarch 30th, 2024
- 'First Big Step Towards a Cure': Revolutionary Type 1 Diabetes Drug at OU HealthApril 11th, 2024
Professional Memberships
- Member
- Pediatric Endocrine SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
